Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in advanced cirrhosis
NCT02862249Phase 3Completed
- Sponsor
- King's College London
- Start
- Mar 2018
- Primary completion
- Sep 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic fecal microbiota in Liver cirrhosis (LC), sponsored by King's College London. Started Mar 2018; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT02862249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02862249.